image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 54.965
-1.43 %
$ 10.4 B
Market Cap
-9.83
P/E
Price Target Average
37.01%
Revenue Forecast Estimate
12.05%
EBIT Estimate
--9.52%
Net Income Estimate
22.71%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Exact Sciences Corporation
image
Wall Street analysts predict an average 1-year price target for EXAS of $75.3 , with forecasts ranging from a low of $60 to a high of $95 .
EXAS Lowest Price Target Wall Street Target
60 USD 9.16%
EXAS Average Price Target Wall Street Target
75.3 USD 37.01%
EXAS Highest Price Target Wall Street Target
95 USD 72.84%
Price
Max Price Target
Min Price Target
Average Price Target
100100909080807070606050504040Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart EXAS

image
$4.5b$4.5b$4.0b$4.0b$3.5b$3.5b$3.0b$3.0b$2.5b$2.5b$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart EXAS

image
$0.0$0.0($500.0m)($500.0m)($1.0b)($1.0b)($1.5b)($1.5b)($2.0b)($2.0b)($2.5b)($2.5b)($3.0b)($3.0b)($3.5b)($3.5b)($4.0b)($4.0b)($4.5b)($4.5b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart EXAS

image
$500.0m$500.0m$0.0$0.0($500.0m)($500.0m)($1.0b)($1.0b)($1.5b)($1.5b)($2.0b)($2.0b)($2.5b)($2.5b)($3.0b)($3.0b)($3.5b)($3.5b)($4.0b)($4.0b)($4.5b)($4.5b)($5.0b)($5.0b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029